LOADING
Comparing Eli Lilly and Company (LLY) and JPMorgan Chase (JPM) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | JPM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $901.6B |
| P/E Ratio | -- | 16.1 |
| Forward P/E | -- | 15.2 |
| PEG Ratio | -- | 1.77 |
| EPS | -- | $20.89 |
| Revenue Growth (YoY) | -- | 12.7% |
| Profit Margin | -- | 33.9% |
| Return on Equity | -- | 16.5% |
| Dividend Yield | -- | 1.76% |
| Beta | -- | 0.98 |
| 52-Week High | -- | $341.91 |
| 52-Week Low | -- | $276.44 |
| Volume | -- | -- |